
Examining the Potential Price Growth of NewAmsterdam Pharma Company NV (NAMS)
In a filing, NewAmsterdam Pharma Company NV revealed its Director Topper James N acquired Company’s shares for reported $25521.0 on
In a filing, NewAmsterdam Pharma Company NV revealed its Director Topper James N acquired Company’s shares for reported $25521.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. NewAmsterdam Pharma
NewAmsterdam Pharma Company NV’s recent filing unveils that its Director Topper James N acquired Company’s shares for reported $84203.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
NewAmsterdam Pharma Company NV’s recently made public that its Director Topper James N acquired Company’s shares for reported $84203.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
NewAmsterdam Pharma Company NV’s filing revealed that its Director Topper James N acquired Company’s shares for reported $84203.0 on Mar
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
NewAmsterdam Pharma Company NV’s recent filing unveils that its Affiliate Douglas F Kling acquired Company’s shares for reported $11.6 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.